Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1982;65:611-617

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahler, F.
Right arrow Articles by Krneta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahler, F.
Right arrow Articles by Krneta, A.

Circulation, Vol 65, 611-617, Copyright © 1982 by American Heart Association


ARTICLES

Lasting improvement of renovascular hypertension by transluminal dilatation of atherosclerotic and nonatherosclerotic renal artery stenoses. A follow-up study

F Mahler, P Probst, M Haertel, P Weidmann and A Krneta

Sixteen consecutive patients with renovascular hypertension were treated by transluminal dilatation and observed during 6 - 39 months (mean 21.8 months). Poststenotic renal artery pressure increased (p less than 0.001) and the renal arteries were patent on angiograms taken immediately after dilatation. In 13 patients, angiography was repeated 2 - 9 months later; at that time the selective renal vein renin ratio had decreased (p less than 0.001). At the end of the follow-up, blood pressure was improved or normal in 14 cases. One of the eight patients with atherosclerosis was normotensive without treatment, compared with five of six patients with fibromuscular dysplasia (p less than 0.05). The results in two cases with vasculitis are uncertain. The four patients with relapses, one after intimal catheter dissection, were treated successfully by redilatation. Thus, renovascular hypertension can be improved by transluminal dilatation in patients with atherosclerosis and in patients with fibromuscular dysplasia with lasting success and a low morbidity rate.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
E. Lohr, K.-D. Bock, F. Eigler, V. Verhagen, K. Sievers, Th. Phillip, and M. Stuschke
Angioplasty of Renal Arteries: A Report of Ten Year's Experience
Angiology, January 1, 1991; 42(1): 44 - 47.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
H. Ohta, T. Takabatake, Y. Yamamoto, Y.-i. Ishida, H. Hara, Y. Ushiogi, S. Nakamura, M. Kawabata, N. Hashimoto, T. Sasaki, et al.
The Long Term Effects of Percutaneous Transluminal Angioplasty for Treating Patients with Renovascular Hypertension: Case Studies
Angiology, July 1, 1986; 37(7): 535 - 542.
[Abstract] [PDF]